SlideShare ist ein Scribd-Unternehmen logo
1 von 6
SCHEDULE TO THE ACT
PRESENTED BY:
Ms. Megha
Assistant Professor
SCHEDULE TO THE ACT
1. FIRST SCHEDULE: It prescribes the list of books specified in Ayurvedic, Siddha or
Unani systems of medicine.
2. SECOND SCHEDULE: It prescribes the standards to be complied with by imported
drugs and by the drugs manufactured for sale, sold stocked or exhibited for sale or
distributed by the drugs manufactured for sale.
In addition, the following appendix are also prescribed:
I- Data required to be submitted with application for permission to market a new drugs.
II- Format for submission of clinical trail reports.
III- Animal toxicity requirement for clinical trail and marketing of a new drugs.
IV- Number of animals for long term toxicity studied.
V- Patient consent form for participation in a phase 1 clinical trails.
VI- Four groups of fixed dose combination and their data requirements.
SCHEDULES TO THE RULES
A- Performa for application for the licenses, issues and renewal of licenses, for sending
memoranda under the Act.
B- Rates of fee for test or analysis by the Central Drugs Laboratory or the state drug
laboratories
B1- Fee for the test or analysis by the pharmacopeia laboratory for Indian medicine or the
govt analyst.
C- List of biological and other special products whose import, sale, distribution and
manufacture are governed by special provision.
C1- List of other special products whose import, sale, distribution and mfg are governed by
special provision.
D- List of drugs exempted from the provisions to import of drugs.
E1- List of poisonous substances under the Ayurvedic (including Siddha) and Unani
systems of medicine.
F- Requirement for the functioning and operation of the blood bank and/or for preparation
of blood components.
F1-
Part I- Provisions applicable to the production of all bacterial and viral vaccine.
Part II- Provisions applicable to the production of all sera from living animal.
Part III- Provisions applicable to the manufacture and standardization of diagnostic
agent (Bacterial origin)
F2- Standards for surgical dressings.
F3- Standards for sterilized umbilical tapes.
FF- Standards of ophthalmic preparations.
G- List of substances that are required to be used only under medical supervision and
which are to be labeled accordingly.
H- List of prescription drugs.
J- Disease or ailments which a drug may not purport to prevent or cure.
K- Drugs exempted from certain provision relating to manufacture of drugs.
L- Good laboratory practice (GLP) and requirement of premises and equipment.
M- Good manufacturing practice (GMP) requirement of factory premises, plants and
equipment.
M1- Requirement of factory premises etc. for manufacture of homeopathic preparation.
M2- Requirement of factory premises etc. for manufacture of cosmetics.
M3- Requirements of factory premises for the manufacture of medical devices.
N- List of minimum equipment for efficient running of a pharmacy.
O- Standard for disinfectant fluid.
P- Life period of drug.
P1- Pack sizes of drug.
Q- List of coals tar colors permitted to be used in cosmetics.
R- Standard for condoms made of rubber latex and other mechanical contraceptives.
R1- Standard for mechanical contraceptive.
S- Standard for cosmetics.
T- Requirement for factory premises and hygienic conditions for Ayurvedic Siddha,
Unani medicines.
U- Particulars to be shown in manufacturing records.
U1- Particulars to be shown in manufacturing, raw material and analytical records of
cosmetic
V- Standard for patent or proprietary medicines.
W- List of drug which is to be marketed under generic names only.
X- List of drugs whose import, manufacture and sale, labeling and packaging are governed
by special provision.
Y- Requirement and guideline for permission to import and manufacture of new drugs for
sale or to undertake clinical trail.
Thank You

Weitere Àhnliche Inhalte

Ähnlich wie Schedule to the act.pptx

Drug regulation
Drug regulationDrug regulation
Drug regulationAbhinab1234
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyHitendra Singh
 
Investigational medical product dossier
Investigational medical product dossierInvestigational medical product dossier
Investigational medical product dossierSachinFartade
 
USFDA Over View
USFDA  Over ViewUSFDA  Over View
USFDA Over ViewTarif Hussian
 
Drug approval in US, EU & India
Drug approval in US, EU & IndiaDrug approval in US, EU & India
Drug approval in US, EU & IndiaSweta Yadav
 
Drug & Cosmetic Act.pdf
Drug & Cosmetic Act.pdfDrug & Cosmetic Act.pdf
Drug & Cosmetic Act.pdfPPALIVE
 
P'JURISPRUDENCE SCHEDULES IN DETAIL RGPV Unit 2 d&c act part 1
 P'JURISPRUDENCE SCHEDULES IN DETAIL RGPV Unit 2 d&c act part 1 P'JURISPRUDENCE SCHEDULES IN DETAIL RGPV Unit 2 d&c act part 1
P'JURISPRUDENCE SCHEDULES IN DETAIL RGPV Unit 2 d&c act part 1shashankc10
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Siddharth Kumar Sahu
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINESRaj Tiwari
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japanManish kumar
 
Schedule Y by akshdeep sharma
Schedule Y by akshdeep sharmaSchedule Y by akshdeep sharma
Schedule Y by akshdeep sharmaAkshdeep Sharma
 
Regulatory Affairs Interview Questions .pdf
Regulatory Affairs Interview Questions .pdfRegulatory Affairs Interview Questions .pdf
Regulatory Affairs Interview Questions .pdfPriyansha Singh
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDANandhanan
 
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptxManufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptxDiwakar Sudhakar Shukla
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesChintamBaladattaSai
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]Akshay Patil
 

Ähnlich wie Schedule to the act.pptx (20)

Schedules
SchedulesSchedules
Schedules
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
 
INDA/NDA/ANDA
INDA/NDA/ANDAINDA/NDA/ANDA
INDA/NDA/ANDA
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
 
Investigational medical product dossier
Investigational medical product dossierInvestigational medical product dossier
Investigational medical product dossier
 
USFDA Over View
USFDA  Over ViewUSFDA  Over View
USFDA Over View
 
Drug approval in US, EU & India
Drug approval in US, EU & IndiaDrug approval in US, EU & India
Drug approval in US, EU & India
 
Usfda ppn
Usfda ppnUsfda ppn
Usfda ppn
 
Drug & Cosmetic Act.pdf
Drug & Cosmetic Act.pdfDrug & Cosmetic Act.pdf
Drug & Cosmetic Act.pdf
 
P'JURISPRUDENCE SCHEDULES IN DETAIL RGPV Unit 2 d&c act part 1
 P'JURISPRUDENCE SCHEDULES IN DETAIL RGPV Unit 2 d&c act part 1 P'JURISPRUDENCE SCHEDULES IN DETAIL RGPV Unit 2 d&c act part 1
P'JURISPRUDENCE SCHEDULES IN DETAIL RGPV Unit 2 d&c act part 1
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
Schedule Y by akshdeep sharma
Schedule Y by akshdeep sharmaSchedule Y by akshdeep sharma
Schedule Y by akshdeep sharma
 
Regulatory Affairs Interview Questions .pdf
Regulatory Affairs Interview Questions .pdfRegulatory Affairs Interview Questions .pdf
Regulatory Affairs Interview Questions .pdf
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDA
 
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptxManufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]
 

Mehr von Meghajoshi86

introduction to drug and cosmetic act.pptx
introduction to drug and cosmetic act.pptxintroduction to drug and cosmetic act.pptx
introduction to drug and cosmetic act.pptxMeghajoshi86
 
Evaulation of protein and peptide delivery.pptx
Evaulation of protein and peptide delivery.pptxEvaulation of protein and peptide delivery.pptx
Evaulation of protein and peptide delivery.pptxMeghajoshi86
 
Protein and peptide drug delivery.pptx
Protein and peptide drug delivery.pptxProtein and peptide drug delivery.pptx
Protein and peptide drug delivery.pptxMeghajoshi86
 
Barriers to protein and peptide delivery.pptx
Barriers to protein and peptide delivery.pptxBarriers to protein and peptide delivery.pptx
Barriers to protein and peptide delivery.pptxMeghajoshi86
 
Introduction to protein and peptide delivery.pptx
Introduction to protein and peptide delivery.pptxIntroduction to protein and peptide delivery.pptx
Introduction to protein and peptide delivery.pptxMeghajoshi86
 
Dissociation Constant.pptx
Dissociation Constant.pptxDissociation Constant.pptx
Dissociation Constant.pptxMeghajoshi86
 
Evaluation of smedds.pptx
Evaluation of smedds.pptxEvaluation of smedds.pptx
Evaluation of smedds.pptxMeghajoshi86
 
Formulation of smedds.pptx
Formulation of smedds.pptxFormulation of smedds.pptx
Formulation of smedds.pptxMeghajoshi86
 
Introduction to smedds.pptx
Introduction to smedds.pptxIntroduction to smedds.pptx
Introduction to smedds.pptxMeghajoshi86
 
Change of states of matter.pptx
Change of states of matter.pptxChange of states of matter.pptx
Change of states of matter.pptxMeghajoshi86
 
States of matter.pptx
States of matter.pptxStates of matter.pptx
States of matter.pptxMeghajoshi86
 
Aerosols.pptx
Aerosols.pptxAerosols.pptx
Aerosols.pptxMeghajoshi86
 
Introduction to Pharmacy.pptx
Introduction to Pharmacy.pptxIntroduction to Pharmacy.pptx
Introduction to Pharmacy.pptxMeghajoshi86
 
Pharmacopoeias.pptx
Pharmacopoeias.pptxPharmacopoeias.pptx
Pharmacopoeias.pptxMeghajoshi86
 

Mehr von Meghajoshi86 (14)

introduction to drug and cosmetic act.pptx
introduction to drug and cosmetic act.pptxintroduction to drug and cosmetic act.pptx
introduction to drug and cosmetic act.pptx
 
Evaulation of protein and peptide delivery.pptx
Evaulation of protein and peptide delivery.pptxEvaulation of protein and peptide delivery.pptx
Evaulation of protein and peptide delivery.pptx
 
Protein and peptide drug delivery.pptx
Protein and peptide drug delivery.pptxProtein and peptide drug delivery.pptx
Protein and peptide drug delivery.pptx
 
Barriers to protein and peptide delivery.pptx
Barriers to protein and peptide delivery.pptxBarriers to protein and peptide delivery.pptx
Barriers to protein and peptide delivery.pptx
 
Introduction to protein and peptide delivery.pptx
Introduction to protein and peptide delivery.pptxIntroduction to protein and peptide delivery.pptx
Introduction to protein and peptide delivery.pptx
 
Dissociation Constant.pptx
Dissociation Constant.pptxDissociation Constant.pptx
Dissociation Constant.pptx
 
Evaluation of smedds.pptx
Evaluation of smedds.pptxEvaluation of smedds.pptx
Evaluation of smedds.pptx
 
Formulation of smedds.pptx
Formulation of smedds.pptxFormulation of smedds.pptx
Formulation of smedds.pptx
 
Introduction to smedds.pptx
Introduction to smedds.pptxIntroduction to smedds.pptx
Introduction to smedds.pptx
 
Change of states of matter.pptx
Change of states of matter.pptxChange of states of matter.pptx
Change of states of matter.pptx
 
States of matter.pptx
States of matter.pptxStates of matter.pptx
States of matter.pptx
 
Aerosols.pptx
Aerosols.pptxAerosols.pptx
Aerosols.pptx
 
Introduction to Pharmacy.pptx
Introduction to Pharmacy.pptxIntroduction to Pharmacy.pptx
Introduction to Pharmacy.pptx
 
Pharmacopoeias.pptx
Pharmacopoeias.pptxPharmacopoeias.pptx
Pharmacopoeias.pptx
 

KĂŒrzlich hochgeladen

How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSCeline George
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxAmanpreet Kaur
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseAnaAcapella
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxDavid Douglas School District
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxcallscotland1987
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 

KĂŒrzlich hochgeladen (20)

Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 

Schedule to the act.pptx

  • 1. SCHEDULE TO THE ACT PRESENTED BY: Ms. Megha Assistant Professor
  • 2. SCHEDULE TO THE ACT 1. FIRST SCHEDULE: It prescribes the list of books specified in Ayurvedic, Siddha or Unani systems of medicine. 2. SECOND SCHEDULE: It prescribes the standards to be complied with by imported drugs and by the drugs manufactured for sale, sold stocked or exhibited for sale or distributed by the drugs manufactured for sale. In addition, the following appendix are also prescribed: I- Data required to be submitted with application for permission to market a new drugs. II- Format for submission of clinical trail reports. III- Animal toxicity requirement for clinical trail and marketing of a new drugs. IV- Number of animals for long term toxicity studied. V- Patient consent form for participation in a phase 1 clinical trails. VI- Four groups of fixed dose combination and their data requirements.
  • 3. SCHEDULES TO THE RULES A- Performa for application for the licenses, issues and renewal of licenses, for sending memoranda under the Act. B- Rates of fee for test or analysis by the Central Drugs Laboratory or the state drug laboratories B1- Fee for the test or analysis by the pharmacopeia laboratory for Indian medicine or the govt analyst. C- List of biological and other special products whose import, sale, distribution and manufacture are governed by special provision. C1- List of other special products whose import, sale, distribution and mfg are governed by special provision. D- List of drugs exempted from the provisions to import of drugs. E1- List of poisonous substances under the Ayurvedic (including Siddha) and Unani systems of medicine. F- Requirement for the functioning and operation of the blood bank and/or for preparation of blood components. F1- Part I- Provisions applicable to the production of all bacterial and viral vaccine. Part II- Provisions applicable to the production of all sera from living animal. Part III- Provisions applicable to the manufacture and standardization of diagnostic agent (Bacterial origin) F2- Standards for surgical dressings.
  • 4. F3- Standards for sterilized umbilical tapes. FF- Standards of ophthalmic preparations. G- List of substances that are required to be used only under medical supervision and which are to be labeled accordingly. H- List of prescription drugs. J- Disease or ailments which a drug may not purport to prevent or cure. K- Drugs exempted from certain provision relating to manufacture of drugs. L- Good laboratory practice (GLP) and requirement of premises and equipment. M- Good manufacturing practice (GMP) requirement of factory premises, plants and equipment. M1- Requirement of factory premises etc. for manufacture of homeopathic preparation. M2- Requirement of factory premises etc. for manufacture of cosmetics. M3- Requirements of factory premises for the manufacture of medical devices. N- List of minimum equipment for efficient running of a pharmacy. O- Standard for disinfectant fluid. P- Life period of drug. P1- Pack sizes of drug. Q- List of coals tar colors permitted to be used in cosmetics. R- Standard for condoms made of rubber latex and other mechanical contraceptives. R1- Standard for mechanical contraceptive. S- Standard for cosmetics. T- Requirement for factory premises and hygienic conditions for Ayurvedic Siddha, Unani medicines. U- Particulars to be shown in manufacturing records.
  • 5. U1- Particulars to be shown in manufacturing, raw material and analytical records of cosmetic V- Standard for patent or proprietary medicines. W- List of drug which is to be marketed under generic names only. X- List of drugs whose import, manufacture and sale, labeling and packaging are governed by special provision. Y- Requirement and guideline for permission to import and manufacture of new drugs for sale or to undertake clinical trail.